Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System.

The Journal of bone and joint surgery. American volume·2026
Same author

Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Nature medicine·2025
Same author

Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in Japan.

Japanese journal of clinical oncology·2025
Same author

Potential Involvement of Myostatin in Smooth Muscle Differentiation in Pleomorphic Leiomyosarcoma.

International journal of molecular sciences·2025
Same author

Patient and physician preferences for cancer panel testing in Japan: a best-worst scaling study.

BMJ open·2025
Same author

Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light Smokers.

Cancer science·2025

Related Experiment Video

Updated: Jun 3, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Proteomic analysis of soft tissue sarcoma.

Yoshiyuki Suehara1

  • 1Department of Orthopaedic Surgery, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan. ysuehara@juntendo.ac.jp

International Journal of Clinical Oncology
|March 9, 2011
PubMed
Summary
This summary is machine-generated.

Proteomics, or global protein expression studies, can identify novel biomarkers for soft tissue sarcomas. These findings aid in early diagnosis and personalized treatment strategies for these rare cancers.

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Area of Science:

  • Oncology
  • Proteomics
  • Biochemistry

Background:

  • Soft tissue sarcomas are diverse malignant mesenchymal tumors.
  • There is a need for new biomarkers and therapeutic targets for improved diagnosis and treatment.
  • Global protein expression analysis (proteomics) offers unique insights into tumor biology.

Purpose of the Study:

  • To highlight the utility of proteomics in soft tissue sarcoma research.
  • To showcase how proteomic studies can identify novel diagnostic and therapeutic biomarkers.
  • To demonstrate the potential for molecular classification of tumors using proteomic data.

Main Methods:

  • Proteomic techniques, including two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry.
  • Analysis of protein expression profiles in soft tissue tumors.
  • Review of recent proteomic studies relevant to soft tissue sarcomas.

Main Results:

  • Proteomic studies provide valuable protein expression profiles of soft tissue tumors.
  • These profiles can lead to the development of novel diagnostic and therapeutic biomarkers.
  • Proteomics enables a more precise molecular classification of tumor subtypes.

Conclusions:

  • Proteomics is a powerful approach for understanding soft tissue sarcoma biology.
  • Proteomic findings are crucial for advancing early diagnosis, targeted therapy, and molecular classification.
  • This review provides examples of recent proteomic studies advancing soft tissue sarcoma management.